Beth C. Seidenberg, Director at Vera Therapeutics, Inc. (VERA), sold 30,299 shares at $42.31 ($1.3M) on 2024-09-19, disclosed to the SEC on 2024-09-20.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.00 | 1,476 | $62K | 4.8% |
| 2 | $42.01 | 1,177 | $49K | 3.9% |
| 3 | $42.31 | 13,823 | $585K | 45.7% |
| 4 | $42.31 | 13,823 | $585K | 45.7% |
| Total | $42.28 avg | 30,299 | $1.3M | 100% |
| Filing → |
| SGMT | BUY | 2023-07-20 | $750K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $23.6M | — | Filing → |
| VERA | BUY | 2023-04-03 | $17K | — | Filing → |